FDA approves Novartis’ $2.1 million gene therapy — making it the world’s most expensive drug
By: Berkeley Lovelace Jr., Angelica LaVito May 24, 2019 The Food and Drug Administration on Friday approved Novartis’ $2.1 million gene therapy for spinal muscular atrophy — making it the world’s most expensive drug. The therapy, Zolgensma, is a one-time treatment for spinal muscular atrophy, a muscle-wasting disease and leading genetic cause of infant mortality […]